Sandra Hoeylaerts - Eurofins Scientific Chief Officer

All Insiders . France . 
Stock . Eurofins Scientific SE . Stakeholders . Insider . Sandra Hoeylaerts
ERF Stock  EUR 48.22  0.41  0.86%   

Insider

Sandra Hoeylaerts is Chief Officer of Eurofins Scientific SE
Phone352 26 18 53 20
Webhttps://www.eurofins.com

Eurofins Scientific Management Efficiency

The company has return on total asset (ROA) of 0.075 % which means that it generated a profit of $0.075 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1521 %, meaning that it generated $0.1521 on every $100 dollars invested by stockholders. Eurofins Scientific's management efficiency ratios could be used to measure how well Eurofins Scientific manages its routine affairs as well as how well it operates its assets and liabilities.
Eurofins Scientific SE has accumulated 2.08 B in total debt with debt to equity ratio (D/E) of 115.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Eurofins Scientific has a current ratio of 1.16, suggesting that it is not liquid enough and may have problems paying out its financial obligations in time and when they become due. Debt can assist Eurofins Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Eurofins Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Eurofins Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Eurofins to invest in growth at high rates of return. When we think about Eurofins Scientific's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Luciana CemerkaTeleperformance SE
N/A
Franois LacosteBiomerieux SA
N/A
Laurence BaucherBarthsDassault Systemes SE
N/A
Yasha MitrottiBiomerieux SA
N/A
Virginie HeuzTeleperformance SE
N/A
Rouven BergmannDassault Systemes SE
50
Florence VerzelenDassault Systemes SE
45
Joachim KreuzburgSartorius Stedim Biotech
58
Agustin GrisantiTeleperformance SE
50
Guillaume BouhoursBiomerieux SA
47
Gregory LambertieWorldline SA
48
Olivier GuitardSartorius Stedim Biotech
N/A
Daniel JulienTeleperformance SE
71
Pascal DalozDassault Systemes SE
54
Heiko ImhlSartorius Stedim Biotech
N/A
Pierre CharbonnierBiomerieux SA
N/A
Mark MillerBiomerieux SA
N/A
Bernard CharlesDassault Systemes SE
66
Alan WintersTeleperformance SE
N/A
Petra KirchhoffSartorius Stedim Biotech
54
Dev MudaliarTeleperformance SE
N/A
Eurofins Scientific SE, through its subsidiaries, provides various analytical testing services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. EUROFINS SCIENT operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 43819 people. Eurofins Scientific SE (ERF) is traded on Euronext Paris in France and employs 61,000 people.

Management Performance

Return On Equity0.15
Return On Asset0.075

Eurofins Scientific Leadership Team

Elected by the shareholders, the Eurofins Scientific's board of directors comprises two types of representatives: Eurofins Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eurofins. The board's role is to monitor Eurofins Scientific's management team and ensure that shareholders' interests are well served. Eurofins Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eurofins Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gilles Martin, Chairman CEO
David Bryant, Sr America
Yvoine Remy, VP Europe
Rajesh Saigal, Ex Asia
Laurent Lebras, Group Director
Sandra Hoeylaerts, Chief Officer
Joachim Reichelt, VP Europe
Gabriel Julia, VP Europe
Valerie Hanote, Ex Director
Timothy Oostdyk, Genomics BioPharma

Eurofins Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Eurofins Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.15
Return On Asset0.075
Current Valuation15.18 B
Shares Outstanding192.56 M
Shares Owned By Insiders32.76 %
Shares Owned By Institutions36.72 %
Price To Earning41.19 X
Price To Book2.67 X
Price To Sales1.83 X
Revenue6.72 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
MSFTMicrosoft
VVisa Class A
CCitigroup

Other Information on Investing in Eurofins Stock

Eurofins Scientific financial ratios help investors to determine whether Eurofins Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eurofins with respect to the benefits of owning Eurofins Scientific security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY